Paul D. Grossman
Chairman of the BoardDr. Paul D. Grossman, Ph.D. served as Board Member at Argonaut Manufacturing Services, Inc. Dr. Grossman serves as Chairman of the Board at Alpha Teknova, Inc. and also serves as its Director since January 2019. He serves as Partner at Telegraph Hill Partners. He served as Venture Partner since joining in February 2014. Dr. Grossman focuses on developing new strategies, sourcing opportunities and supporting growth of its existing portfolio companies. He serves on the Board of Specific Diagnostics, LLC since September 6, 2019. He served as Director at Agena Bioscience, Inc. Dr. Grossman served as Senior Vice President of Strategy and Corporate Development and Head of Global Strategy and Corporate Development at Life Technologies Corporation, where he was in charge of corporate strategies, licensing, business development and acquisition activity. Dr. Grossman held the same position at Invitrogen Corporation prior to the merger with Applied Biosystems in 2008. Prior to Invitrogen, Dr. Grossman held a variety of leadership roles during at Applied Biosystems (ABI). Dr. Grossman served as Head of Intellectual Property of Celera Corporation. He served as Head - Intellectual Property - Applied Biosystems Group at Applied Biosystems, Inc. Dr. Grossman served as an Executive Officer of Intellectual Property for Applied Biosystems at Applera Corp. Dr. Grossman served as an Assistant Secretary of Applera Corp-applied Biosystems Group. He served as Vice President of Strategy Planning and Business Development of Applied Biosystems Ltd., since 2005. He served as Vice President of Intellectual Property and Chief Group Counsel of Applied Biosystems Group. He served as Vice President of Strategy & Business Development of Applied Biosystems Inc. since 2005. He joined Applied Biosystems in 1983 as a Research Associate. He served as a Senior Patent Attorney. Prior to joining the legal department as a Patent Agent in 1993, he held various positions in research and development and also served as a research scientist. He served as Director at Rhythm Diagnostic Systems, Inc. He served as Director of Nimble Therapeutics, Inc. He has authored numerous scientific publications, was a co-editor of the book Capillary Electrophoresis: Theory and Practice and holds more than 70 U.S. and foreign patents. Dr. Grossman has spearHeaded the acquisition or divestment of more than 25 businesses, including the merger of Invitrogen and Applied Biosystems and was responsible for a corporate development strategy that included novel approaches to grow and monetize the company's substantial intellectual property portfolio of over 4,000 patents and licenses. He serves on the Board of Excellos, Incorporated (formerly known as Community Bio, Inc.) since January 25, 2022. Dr. Grossman has experience within the laboratory tools and instruments sector. Dr. Grossman received a Ph.D. in Chemical Engineering from University of California, Berkeley in 1991 and a JD from Santa Clara University Law School in 1997. He also received a M.S. Degree in Chemical Engineering from University of Virginia in 1987 and a B.S. degree in Chemical Engineering from University of California, Berkeley in 1983.
Positions
- Company NameAlpha Teknova, Inc.Stock CodeTKNOPositionChairman of the BoardColleagues
- SGStephen GunstreamPresident, CEO & Director
- MCMatthew C. LowellChief Financial Officer
- DADamon A. TerrillGeneral Counsel, Chief Compliance Officer & Secretary
- JHJennifer HenrySenior Vice President of Marketing
- BMBrett M. RobertsonIndependent Director
- AVAlexander VosIndependent Director
- MJMartha J. DemskiIndependent Director
